BX
Baudax Bio, Inc.
BXRXQ · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $4.36K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.00x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 452.33%
FCF margin 2,191.73%
Net margin 4,633.18%
Quality
59 /100
Average ROIC 974.83%
Asset turnover 0.13x
ROA 586.08%
Debt
70 /100
Low Current ratio 0.30x
Net debt/EBITDA -0.06x
Debt/Equity N/A
Stability
14 /100
Unstable Beta 9.17x
Profitable years 0
EPS volatility 55.97%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BXRXQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gerri Henwood
Employees
9
Headquarters
Malvern
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report